CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Common Shares Offering	Common Shares	Additional Paid in Capital	Accumulated Deficit	Noncontrolling Interest	Offering	Total
Beginning Balance at Sep. 30, 2022		$ 645	$ 305,411,272	$ (292,500,088)	$ (2,890)		$ 12,908,939
Beginning Balance (in shares) at Sep. 30, 2022		645,426
Increase (Decrease) in Stockholders' Equity
Stock based compensation expense			93,748				93,748
Net income (loss)				(3,843,372)	(874)		(3,844,246)
Ending Balance at Dec. 31, 2022		$ 645	305,505,020	(296,343,460)	(3,764)		9,158,441
Ending Balance (in shares) at Dec. 31, 2022		645,426
Beginning Balance at Sep. 30, 2022		$ 645	305,411,272	(292,500,088)	(2,890)		12,908,939
Beginning Balance (in shares) at Sep. 30, 2022		645,426
Increase (Decrease) in Stockholders' Equity
Net income (loss)							(3,293,070)
Ending Balance at Mar. 31, 2023		$ 645	305,763,624	(295,755,117)	(40,931)		9,968,221
Ending Balance (in shares) at Mar. 31, 2023		645,426
Beginning Balance at Dec. 31, 2022		$ 645	305,505,020	(296,343,460)	(3,764)		9,158,441
Beginning Balance (in shares) at Dec. 31, 2022		645,426
Increase (Decrease) in Stockholders' Equity
Stock based compensation expense			258,604				258,604
Net income (loss)				588,343	(37,167)		551,176
Ending Balance at Mar. 31, 2023		$ 645	305,763,624	(295,755,117)	(40,931)		9,968,221
Ending Balance (in shares) at Mar. 31, 2023		645,426
Beginning Balance at Sep. 30, 2023		$ 683	307,397,623	(302,447,147)	(78,747)		$ 4,872,412
Beginning Balance (in shares) at Sep. 30, 2023		682,926					682,926
Increase (Decrease) in Stockholders' Equity
Stock based compensation expense			340,705				$ 340,705
Exercise of options cashlessly		$ 1	(1)
Exercise of options cashlessly (in shares)		105
Common stock issued		$ (4)	(45,562)				(45,566)
Common stock issued (In shares)		4,397
Deemed dividend - warrant repricing			77,757	(77,757)
Net income (loss)				(1,105,100)	(25,181)		(1,130,281)
Ending Balance at Dec. 31, 2023		$ 688	307,861,646	(303,630,004)	(103,928)		4,128,402
Ending Balance (in shares) at Dec. 31, 2023		687,428
Beginning Balance at Sep. 30, 2023		$ 683	307,397,623	(302,447,147)	(78,747)		$ 4,872,412
Beginning Balance (in shares) at Sep. 30, 2023		682,926					682,926
Increase (Decrease) in Stockholders' Equity
Common stock issued (In shares)							4,501
Deemed dividend - warrant repricing						$ 155,330
Net income (loss)							$ (5,624,064)
Ending Balance at Mar. 31, 2024		$ 864	308,206,796	(308,255,808)	(127,237)		$ (175,385)
Ending Balance (in shares) at Mar. 31, 2024		863,068					682,926
Beginning Balance at Dec. 31, 2023		$ 688	307,861,646	(303,630,004)	(103,928)		$ 4,128,402
Beginning Balance (in shares) at Dec. 31, 2023		687,428
Increase (Decrease) in Stockholders' Equity
Stock based compensation expense			171,004				171,004
Common stock issued	$ 161	$ 1	18,830			$ 161	18,831
Common stock issued (In shares)	161,403	105
Deemed dividend - warrant repricing			155,330	(155,330)
Share issued upon restricted stock vesting (in shares)		14,132
Share issued upon restricted stock vesting		$ 14	(14)
Net income (loss)				(4,470,474)	(23,309)		(4,493,783)
Ending Balance at Mar. 31, 2024		$ 864	$ 308,206,796	$ (308,255,808)	$ (127,237)		$ (175,385)
Ending Balance (in shares) at Mar. 31, 2024		863,068					682,926